Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Anderson

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2015
Strategies for successfully navigating the pharmacy residency interview processSarah L Anderson
Drugs in Context|July 30, 2025
Review: Special Issue: <i>Real-world evidence on the use of GLP1 receptor agonists</i>: Emerging concepts in obesity management: focus on glucagon receptor agonist combinationsSarah L Anderson
Drugs in Context|February 16, 2026
Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavirSarah L Anderson
Therapeutic Advances in Drug Safety|December 2, 2014
Dapagliflozin efficacy and safety: a perspective reviewSarah L Anderson
Drugs in Context|June 3, 2026
New and emerging treatments for PBC-related pruritusSarah L Anderson
Diabetes Spectrum : a Publication of the American Diabetes Association|August 31, 2016
Basal Insulin Use With GLP-1 Receptor AgonistsSarah L Anderson, Jennifer M Trujillo
European Endocrinology|April 11, 2018
Antihyperglycemic Medications and Cardiovascular Risk ReductionSarah L Anderson, Joel C Marrs
Nature and Science of Sleep|July 30, 2016
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexantJessica L Norman, Sarah L Anderson
Therapeutic Advances in Chronic Disease|January 16, 2016
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulnessSarah L Anderson, Jennifer M Trujillo
Patient Preference and Adherence|June 14, 2014
Once-weekly albiglutide in the management of type 2 diabetes: patient considerationsHeather N Woodward, Sarah L Anderson
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2015
Strategies for successfully navigating the pharmacy residency interview processSarah L Anderson
Drugs in Context|July 30, 2025
Review: Special Issue: <i>Real-world evidence on the use of GLP1 receptor agonists</i>: Emerging concepts in obesity management: focus on glucagon receptor agonist combinationsSarah L Anderson
Drugs in Context|February 16, 2026
Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavirSarah L Anderson
Therapeutic Advances in Drug Safety|December 2, 2014
Dapagliflozin efficacy and safety: a perspective reviewSarah L Anderson
Drugs in Context|June 3, 2026
New and emerging treatments for PBC-related pruritusSarah L Anderson
Diabetes Spectrum : a Publication of the American Diabetes Association|August 31, 2016
Basal Insulin Use With GLP-1 Receptor AgonistsSarah L Anderson, Jennifer M Trujillo
European Endocrinology|April 11, 2018
Antihyperglycemic Medications and Cardiovascular Risk ReductionSarah L Anderson, Joel C Marrs
Nature and Science of Sleep|July 30, 2016
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexantJessica L Norman, Sarah L Anderson
Therapeutic Advances in Chronic Disease|January 16, 2016
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulnessSarah L Anderson, Jennifer M Trujillo
Patient Preference and Adherence|June 14, 2014
Once-weekly albiglutide in the management of type 2 diabetes: patient considerationsHeather N Woodward, Sarah L Anderson
Pageof 6